Search Results for ""drugs for""
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for "drugs for". Results 2591 to 2596 of 2596 total matches.
New Glucose-monitoring Technologies
The Medical Letter on Drugs and Therapeutics • Dec 08, 2003 (Issue 1171)
The Medical Letter
®
On Drugs and Therapeutics
www.medicalletter.org
Published by The Medical Letter, Inc ...
Improved glucose meters and 2 sensing systems for continuous monitoring have become available for management of diabetes.
COVID-19 Update: Novavax Vaccine for 2024-2025
The Medical Letter on Drugs and Therapeutics • Oct 28, 2024 (Issue 1714)
formulations
for 2024-2025. Med Lett Drugs Ther 2024; 66:151.
4. COVID-19 Real-Time Learning Network. COVID ...
A 2024-2025 formulation of the Novavax adjuvanted
protein subunit COVID-19 vaccine that more
closely targets currently circulating SARS-CoV-2
variants is available now under an FDA Emergency
Use Authorization (EUA) for use in persons ≥12
years old. The 2024-2025 formulations of the
mRNA COVID-19 vaccines manufactured by Pfizer/BioNTech (Comirnaty) and Moderna (Spikevax) were licensed by the FDA last month for use in persons ≥12
years old and made available under EUAs for use in
persons 6 months to 11 years old.
Med Lett Drugs Ther. 2024 Oct 28;66(1714):175-6 doi:10.58347/tml.2024.1714d | Show Introduction Hide Introduction
Shield — A Blood Test for Colorectal Cancer Screening
The Medical Letter on Drugs and Therapeutics • Jun 09, 2025 (Issue 1730)
– an at-home stool DNA test for colorectal
cancer screening. Med Lett Drugs Ther 2025; 67:73.
9. TR Church et ...
The FDA has approved Shield (Guardant), a DNA
blood test, for colorectal cancer (CRC) screening
in average-risk adults ≥45 years old. Shield is the
second blood-based DNA test to be approved for CRC
screening; ColoHealth (formerly Epi proColon) was
approved in 2016.
Med Lett Drugs Ther. 2025 Jun 9;67(1730):90-2 doi:10.58347/tml.2025.1730b | Show Introduction Hide Introduction
Lasik and Its Alternatives: An Update
The Medical Letter on Drugs and Therapeutics • Jan 19, 2004 (Issue 1174)
to the cost ($500 to $2500 per eye) of conventional LASIK.
5
The Medical Letter
®
On Drugs ...
Since the last Medical Letter article on surgical correction of refractive errors (Volume 41, page 122, 1999), some new techniques have been tried and new results have been reported.
Cord Blood Banks
The Medical Letter on Drugs and Therapeutics • Oct 01, 2001 (Issue 1114)
The Medical Letter
On Drugs and Therapeutics
www.medletter.com
Published by The Medical ...
Pregnant women now often receive promotional material from private cord blood banks urging them to save and store their babies' cord blood.
Expanded Table: Some Vaccines for Travelers (online only)
The Medical Letter on Drugs and Therapeutics • Nov 19, 2018 (Issue 1560)
the risk of transmission (e.g. injection
drug use, unprotected sexual contact,
medical tourism ...
View the Expanded Table: Some Vaccines for Travelers